Publication:
Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.

dc.contributor.authorChin, Suet-Feung
dc.contributor.authorSantonja, Angela
dc.contributor.authorGrzelak, Marta
dc.contributor.authorAhn, Soomin
dc.contributor.authorSammut, Stephen-John
dc.contributor.authorClifford, Harry
dc.contributor.authorRueda, Oscar M
dc.contributor.authorPugh, Michelle
dc.contributor.authorGoldgraben, Mae A
dc.contributor.authorBardwell, Helen A
dc.contributor.authorCho, Eun Yoon
dc.contributor.authorProvenzano, Elena
dc.contributor.authorRojo, Federico
dc.contributor.authorAlba, Emilio
dc.contributor.authorCaldas, Carlos
dc.date.accessioned2024-02-08T14:41:10Z
dc.date.available2024-02-08T14:41:10Z
dc.date.issued2018-03-31
dc.description.abstractPathology archives with linked clinical data are an invaluable resource for translational research, with the limitation that most cancer samples are formalin-fixed paraffin-embedded (FFPE) tissues. Therefore, FFPE tissues are an important resource for genomic profiling studies but are under-utilised due to the low amount and quality of extracted nucleic acids. We profiled the copy number landscape of 356 breast cancer patients using DNA extracted FFPE tissues by shallow whole genome sequencing. We generated a total of 491 sequencing libraries from 2 kits and obtained data from 98.4% of libraries with 86.4% being of good quality. We generated libraries from as low as 3.8 ng of input DNA and found that the success was independent of input DNA amount and quality, processing site and age of the fixed tissues. Since copy number alterations (CNA) play a major role in breast cancer, it is imperative that we are able to use FFPE archives and we have shown in this study that sWGS is a robust method to do such profiling.
dc.format.number3es_ES
dc.format.page161-169es_ES
dc.format.volume104es_ES
dc.identifier.doi10.1016/j.yexmp.2018.03.006
dc.identifier.e-issn1096-0945es_ES
dc.identifier.journalExperimental and molecular pathologyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/12297
dc.identifier.pubmedID29608913es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17584
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCopy number (CN) and breast cancer
dc.subjectFormalin-fixed paraffin-embedded (FFPE)
dc.subjectShallow whole genome sequencing (sWGS)
dc.subject.meshBiomarkers, Tumor
dc.subject.meshBreast Neoplasms
dc.subject.meshCase-Control Studies
dc.subject.meshDNA
dc.subject.meshDNA Copy Number Variations
dc.subject.meshFemale
dc.subject.meshFormaldehyde
dc.subject.meshGene Expression Profiling
dc.subject.meshGenomics
dc.subject.meshHigh-Throughput Nucleotide Sequencing
dc.subject.meshHumans
dc.subject.meshNeoplasm Invasiveness
dc.subject.meshParaffin Embedding
dc.subject.meshSequence Analysis, DNA
dc.subject.meshTissue Fixation
dc.subject.meshWhole Genome Sequencing
dc.titleShallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files